According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

Weight loss journeys are as unique as the individuals who embark on them. We all have different body types, lifestyles, health histories and goals that shape what we need to achieve lasting results.

Amycretin targets GLP-1 and amylin hormones, seen as potential best-in-class therapy Novo shares rise over 5% after amycretin trial results Amycretin aids significant weight loss and glucose control ...

The Miami Beach-based practice integrates the newly approved oral GLP-1 into its physician-supervised weight management ...

Data: N.C. Department of Health and Human Services; Chart: Axios Visuals North Carolina is one of 13 states whose Medicaid programs cover GLP-1s for weight loss treatment, and their usage in the state ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

A comprehensive analysis conducted by researchers at the University of Oxford, encompassing over 6,000 adults, revealed that individuals who discontinued GLP-1 medications regained weight at an ...

Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start of the new year.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Gabby Landsverk Every time Gabby publishes a story, you’ll get an alert straight to your inbox!

Nearly 115 million American adults, more than one in three aged 18 and older, have prediabetes, a condition where blood sugar ...

Oprah Winfrey has long been an influential figure in the health and wellness industry. Her recent comments about GLP-1s mark a turning point in how we think about losing weight. Experts said she ...